SCHEMBL22029351

SCHEMBL22029351

CC(C)(C)OC(=O)CCCCCCCCCCCCCc1ccc(Oc2ccc(S(=O)(=O)Nc3cnc(C(=O)NCCC(=O)O)nc3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.39
▸ FABP1 P07148 1/20 0.37
▸ PLAAT3 P53816 1/20 0.37
▸ PLAAT5 Q96KN8 1/20 0.37
▸ PLAAT2 Q9NWW9 1/20 0.37
▸ PLAAT4 Q9UL19 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ TBXA2R P21731 1/20 0.37
▸ TBXAS1 P24557 1/20 0.37
▸ NAMPT P43490 4/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NR3C1 P04150 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ ADRB3 P13945 1/20 0.36
▸ RXRA P19793 1/20 0.36
▸ NR1H2 P55055 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22029370 0.89 TDP1 (0.41) TDP1POLBALDH1A1FABP1PLAAT3
SCHEMBL31682037 0.88 PKM (0.39) TDP1POLBALDH1A1PLAAT3PLAAT5
SCHEMBL22029365 0.87 ALDH1A1 (0.38) TDP1POLBALDH1A1HDAC1TBXA2R
SCHEMBL22029391 0.85 CA12 (0.48) ALDH1A1FABP1HDAC1HDAC8
SCHEMBL31682053 0.84 HDAC1 (0.44) TDP1POLBALDH1A1FABP1HDAC1
SCHEMBL31682055 0.84 HDAC1 (0.44) TDP1POLBALDH1A1FABP1HDAC1
SCHEMBL31681994 0.83 ALDH1A1 (0.40) ALDH1A1HDAC1TBXA2RTBXAS1NAMPT
SCHEMBL31682054 0.83 ALDH1A1 (0.40) ALDH1A1HDAC1TBXA2RTBXAS1NAMPT
SCHEMBL31682105 0.83 PKM (0.40) TDP1POLBALDH1A1FABP1HDAC1
SCHEMBL31681968 0.82 POLB (0.50) TDP1POLBHDAC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3893934-B1 INSULIN CONJUGATES SANOFI SA (FR) 2025-09-10 — — EP disclosed
US-12195510-B2 Insulin conjugates SANOFI (FR) 2025-01-14 — — US disclosed
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 — — US disclosed
US-20200181223-A1 INSULIN CONJUGATES SANOFI (FR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181223-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885POLB 4107/4885ALDH1A1 1829/4885
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885POLB 4107/4885ALDH1A1 1829/4885
US-12195510-B2 Insulin conjugates IAPP, INSR, IGF1R TDP1 4783/4885POLB 4107/4885ALDH1A1 1829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback